Market Currents
ACADIA Pharmaceuticals (ACAD) moves higher in after-hours trade following the announcement that...
-
Monday, November 26, 2012, 6:01 PM ETACADIA Pharmaceuticals (ACAD) moves higher in after-hours trade following the announcement that it will host a conference call and webcast at 8:00 a.m. EST on Tuesday, November 27, to present the top-line results from its Phase III trial of pimavanserin, a treatment for patients with Parkinson's disease psychosis. Shares +6.5% AH.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment: